Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Access to Medicare Act of 2014
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Protecting Access to Medicare Act, HR 4302
Patent Abuse Reduction Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2018 · first_quarter · Q1
Orphan Drug Act Medicaid Reform Drug Pricing Right to Try Third party payments for co-pays and premium assistance Medicare Part D coinsurance
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance Medicare Part D Coinsurance
Source: Senate LDA
Patent Abuse Reduction Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Abuse Reduction Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Abuse Reduction Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Iprovements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Transparency and Improvements Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Transparency and Improvements Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Iprovements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Transparency and Improvements Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Patent Transparency and Improvements Act of 2013
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Prescription Drug User Fee (PDUFA) Reauthorization Pharmaceutical Supply Chain issues TREAT Act (S. 2113); FAST Act (H.R. 4132); ULTRA Act (H.R. 3737)
Prescription Drug User Fee (PDUFA) Reauthorization Pharmaceutical Supply Chain issues TREAT Act (S. 2113); FAST Act (H.R. 4132); ULTRA Act (H.R. 3737)
Repealing the Job-Killing Health Care Law Act
Client: ALEXION PHARMACEUTICALS, INC. · Firm: ALEXION PHARMACEUTICALS, INC.
Repealing the Job Killing Health Care Law Act (H.R. 2) PPACA Implementation
Trade Policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2017 · fourth_quarter · Q4
Trade Policy
Orphan Drug Act Drug Pricing ACA Repeal & Replace Right to Try Third party payments for co-pays and premium assistance RACE for Children Act CHIP
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance Medicare Part D Coinsurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2017 · third_quarter · Q3
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance
Orphan Drug Act Drug Pricing ACA Repeal & Replace Right to Try Third party payments for co-pays and premium assistance RACE for Children Act
Trade Policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2017 · second_quarter · Q2
Trade Policy
Orphan Drug Act Drug Pricing ACA Repeal & Replace Right to Try Third party payments for co-pays and premium assistance RACE for Children Act
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2017 · first_quarter · Q1
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance
Trade Policy
Orphan Drug Act Drug Pricing ACA Repeal & Replace
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2016 · fourth_quarter · Q4
Drug Pricing Creates ACT (REMs) CURES Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues PDUFA
TTP TTIP TPA
CMS Part B DEMO CMMI Medicaid Reform; Texas Medicaid Medicare Hospital Inpatient Payment Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2016 · third_quarter · Q3
CMS Part B DEMO Medicaid Reform; Texas Medicaid Medicare Hospital Inpatient Payment Reform
TTP TTIP TPA
Drug Pricing Creates ACT (REMs) CURES Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2016 · second_quarter · Q2
Creates ACT (REMs) Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues Biosimilars Implementation
TTP TTIP TPA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2016 · first_quarter · Q1
TTP TTIP TPA
ACA Implementation 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2015 · fourth_quarter · Q4
TTP TTIP TPA
ACA Implementation 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2015 · third_quarter · Q3
ACA Implementation 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2015 · second_quarter · Q2
ACA Implementation 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2015 · first_quarter · Q1
ACA Implementation 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · fourth_quarter · 4A
21st Century Cures Initiative Biosimilars (BPCIA/ACA) Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · fourth_quarter · Q4
21st Century Cures Initiative Biosimilars (BPCIA/ACA) Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · third_quarter · Q3
ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton) Biosimilars
Tax Reform Act of 2014 (Chairman Camp Draft) Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · second_quarter · Q2
Tax Reform Act of 2014 (Chairman Camp Draft) Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act
ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton) Biosimilars
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · first_quarter · Q1
ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton)
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Tax Reform Act of 2014 Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2014 · first_quarter · Q1
Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Iprovements Act, S. 1720 Patent Abuse Reduction Act, S. 1013
Protecting Access to Medicare Act, HR 4302
ACA Implementation Issues
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2013 · fourth_quarter · Q4
ACA Implementation issues, including health exchanges, biosimilars Track & Trace; pharmaceutical compounding Implementation legislation 340B issues Budget/Sequester issues impacting Medicare/Medicaid (SGR) and FDA user fees
Comprehensive Tax Reform proposals Patent Box proposals Orphan Drug Tax Credit R&D Tax Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2013 · third_quarter · Q3
Comprehensive tax reform proposals Patent Box proposals Orphan Drug Tax Credit
ACA Implementation issues, including health exchanges and biosimilars Track & Trace; pharmaceutical compounding legislation 340B Issues Budget/Debt limit issues impacting Medicare, Medicaid, the FDA and federal health systems
EU FTA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2013 · second_quarter · Q2
Comprehensive Tax Reform proposals (Camp; Baucus/Hatch) Patent Box Proposals (Feinstein/Schwartz) Orphan Drug Tax Credit
EU FTA
ACA Implementation issues (specialty tiering, health insurance exchanges) Track & Trace legislation (Burr & Harkin) Sequestration issues impacting Medicare, Medicaid, the FDA and federal health programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2013 · first_quarter · Q1
Tax Reform Issues; Chairman Camp Draft Patent Box Draft proposals, Rep. Schwartz; Sen. Feinstein Tax Issues in Fiscal Cliff Legislation
Pre-Existing Condition Insurance Program (Upton, Burgess) Track & Trace Draft Legislation (Burr & Harkin) Health Insurance Exchanges under the ACA Sequestration and fiscal cliff issues impacting Medicare, Medicaid and federal health programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2012 · fourth_quarter · Q4
2013 Sequestration and fiscal cliff issues impacting Medicare, Medicaid and federal health programs
Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein patent box draft Tax issues in fiscal cliff legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2012 · third_quarter · Q3
Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein Patent Box draft
Food and Drug Administration Safety and Innovation Act (S. 3187) 2013 sequestration issues
Korea-US Free Trade Agreement implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2012 · second_quarter · Q2
Food and Drug Administration Safety and Innovation Act (S. 3187) Camp Draft on Tax Reform Rep. Schwartz Patent Box draft Senator Feinstein Patent Box draft
Korea- US Free Trade Agreement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2012 · first_quarter · Q1
Korea-US Free Trade Agreement
Prescription Drug User Fee (PDUFA) Reauthorization Pharmaceutical Supply Chain issues TREAT Act (S. 2113); FAST Act (H.R. 4132); ULTRA Act (H.R. 3737)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2011 · fourth_quarter · Q4
Monitor deficit reduction initiatives, including Budget Control Act of 2011 and "Super Committee" deliberations; Prescription Drug User Fee Act (PDUFA) Reathorization
Korea/US Free Trade Agreement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2011 · third_quarter · Q3
Korea US Free Trade Agreement
Monitor implementation of PPACA, including provisions relating to orphan drugs and regulatory pathway for biosimilars. Monitor deficit reduction initatives, including Budget Control Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2011 · second_quarter · Q2
Monitor implementation of PPACA, including provisions relating to orphan drugs and regulatory pathway for biosimilars. Monitor deficit reduction initiatives.
Korea FTA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2011 · first_quarter · Q1
Repealing the Job Killing Health Care Law Act (H.R. 2) PPACA Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2010 · fourth_quarter · Q4
American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213) Americans', Seniors' and Childrens' Health Technical Corrections Act of 2010 PPACA Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2010 · third_quarter · Q3
American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213) Veterans', Seniors' and Childrens' Health Technical Corrections Act of 2010 PPACA Implementation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2010 · second_quarter · Q2
American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213) Veterans', Seniors' and Childrens' Health Technical Corrections Act of 2010 PPACA Implementation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2010 · second_quarter · Q2
Implementation of Patient Protection & Affordable Care Act Veterans, Seniors, and Childrens Health Technical Corrections Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2010 · first_quarter · Q1
Patient Protection & Affordable Care Act Health Care & Education Affordability Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2009 · fourth_quarter · Q4
Patient Protection & Affordable Care Act Affordable Health Care for America Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2009 · fourth_quarter · RR
Health care reform: Patient Protection & Affordable Care Act Affordable Health Care for America Act
Health care reform: Patient Protection & Affordable Care Act Affordable Health Care for America Act
ALEXION PHARMACEUTICALS, INC. via ALEXION PHARMACEUTICALS, INC.
2009 · fourth_quarter · RR
Health care reform Follow-on Biologics Medicare/Medicaid Reimbursement
Health care reform Follow-on Biologics Medicare/Medicaid Reimbursement
TTP TTIP
Tax Reform Act of 2014 (Chairman Camp Draft) Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE